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Introduction: Monocytes are essential phagocytic cells of the innate immune system as they are 
required for the maintenance of tissue homeostasis. However, accumulation of monocytes is 
implicated in various chronic inflammatory diseases like coronary heart disease, atherosclerosis 
and in autoimmune disorders. Therefore, the number of monocytes must be carefully regulated to 
avoid monocyte induced inflammatory disorders. Mesenchymal stem cells (MSCs) have shown to 
be effective against various inflammatory diseases due to their immunosuppressive properties. The 
present study was designed to evaluate the less understood immunomodulatory effect of MSCs on 
monocyte proliferation and survival. Method: Primary monocytes were isolated from peripheral 
human blood using CD14+ monocyte isolation kit. The in house produced umbilical cord MSCs 
were co-cultured with monocytes at different ratio and time; assessed for the monocyte viability, 
proliferation and cell cycle. Results: Mesenchymal stem cells suppressed monocyte proliferation 
in a dose-dependent manner. The antiproliferative effect of MSCs was mediated by cell cycle 
arrest, whereby monocytes were arrested in the G0/G1 phase of the cell cycle by preventing them 
from progress into S and G2/M phases. Although cell cycle arrest could potentially lead to 
apoptosis; however, MSCs significantly enhanced the monocytes survival and inhibited apoptosis. 
Conclusion: Human MSCs inhibit the stimulated monocyte proliferation without inducing cellular 
apoptosis at in vitro. These results reveal that MSCs can be utilised to control monocytes’ quantity 
during an unwanted immune response to maintain homeostasis. 
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